ロード中...
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) convened a w...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6278162/ https://ncbi.nlm.nih.gov/pubmed/30514399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0453-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|